Medicare Enrolled

Dr. Jorge Cheirif, MD

Cardiovascular Disease · Dallas, TX
Practice pattern: Electrophysiology & Cardiac— Practice combining electrophysiology and cardiac services
Speaking/Promotional
8440 WALNUT HILL LN STE 610, Dallas, TX 75231
2143456000
In practice since 2006 (19 years)
NPI: 1598703803 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cheirif from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cheirif? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cheirif

Dr. Jorge Cheirif is a cardiovascular disease in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. Cheirif performed 3,025 Medicare services across 2,645 unique beneficiaries.

Between the years covered by Open Payments, Dr. Cheirif received a total of $141,545 from 48 pharmaceutical and/or device companies across 508 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cheirif is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 34% volume in TX$ $141,545 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,025
Medicare services
Top 34% in TX for cardiovascular disease
2,645
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~159 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)850$89$323
Electrocardiogram (EKG), 12-lead611$10$65
Echocardiogram, transthoracic220$141$734
Hospital follow-up visit, moderate complexity181$61$238
Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report173$172$781
Ultrasound of heart blood flow, valves and chambers172$40$241
Ultrasound of heart with color-depicted blood flow, rate and valve function159$19$222
Ultrasound of heart with probe in esophagus, with report141$82$281
New patient office visit (45-59 min)139$114$500
3d radiographic procedure109$7$25
Initial hospital admission, moderate complexity81$100$455
Office visit, established patient, complex (40-54 min)56$135$435
External shock to heart to regulate heart beat39$81$806
Ultrasound of both sides of head and neck blood flow39$141$789
New patient office visit, complex (60-74 min)24$168$622
Injection, perflutren lipid microspheres, per ml18$35$130
Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional13$17$82
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
18.2% high complexity
12.3% medium
69.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$141,545
Total received (2018-2024)
Avg $20,221/year across 7 years
Top 4% in TX for cardiovascular disease
48
Companies
508
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$135,146 (95.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,327 (4.5%)
Other
Charitable contributions, space rental, and other categories
$56 (0.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$16 (0.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,824
2023
$9,141
2022
$12,687
2021
$11,491
2020
$15,986
2019
$39,669
2018
$50,746

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$69,145
SANOFI-AVENTIS U.S. LLC
$16,084
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$13,139
Novartis Pharmaceuticals Corporation
$11,313
Regeneron Healthcare Solutions, Inc.
$11,259
AstraZeneca Pharmaceuticals LP
$9,798
Gilead Sciences, Inc.
$5,139
Abbott Laboratories
$1,252
Actelion Pharmaceuticals US, Inc.
$600
Merck Sharp & Dohme LLC
$424
PFIZER INC.
$386
Boston Scientific Corporation
$357
E.R. Squibb & Sons, L.L.C.
$288
Itamar Medical Inc
$259
Esperion Therapeutics, Inc.
$251
HEARTFLOW, INC.
$215
Amgen Inc.
$153
ABIOMED
$149
Boehringer Ingelheim Pharmaceuticals, Inc.
$140
Lexicon Pharmaceuticals, Inc.
$133
SCPHARMACEUTICALS INC.
$95
Astellas Pharma US Inc
$79
Amarin Pharma Inc.
$75
Kiniksa Pharmaceuticals, Ltd.
$66
Medtronic, Inc.
$64
Novo Nordisk Inc
$60
Bardy Diagnostics, Inc.
$56
Baxter Healthcare
$56
Philips Electronics North America Corporation
$49
United Therapeutics Corporation
$43
VivaQuant Inc, dba Rhythm Express
$39
CVRx, Inc.
$38
HeartFlow, Inc.
$32
PORTOLA PHARMACEUTICALS, INC.
$30
Merck Sharp & Dohme Corporation
$29
Daiichi Sankyo Inc.
$28
Inspire Medical Systems, Inc.
$23
MEDICOMP INC
$22
BOSTON SCIENTIFIC CORPORATION
$21
Otsuka America Pharmaceutical, Inc.
$21
Siemens Medical Solutions USA, Inc.
$20
Regeneron Pharmaceuticals, Inc.
$20
Azurity Pharmaceuticals, Inc.
$18
ARALEZ PHARMACEUTICALS US INC.
$17
Kiniksa Pharmaceuticals International, plc
$16
Noden Pharma USA Inc
$15
Lilly USA, LLC
$14
Tactile Systems Technology Inc
$13
Top 3 companies account for 69.5% of total payments
Associated products mentioned in payments ›
(5050) Extended Holter · (7999) SRC Undivided · ACCOLADE · ANDEXXA · Arcalyst · Artis Q · Azure · BEVYXXA · BRILINTA · Barostim Neo System · CAMZYOS · CardioMEMS HF System · Carnation Ambulatory Monitor · Corlanor · EDARBI · ELIQUIS · EMBLEM S ICD ELECTRODE DELIVERY SYSTEM · ENTRESTO · FARXIGA · FFRct · FLEXITOUCH · FUROSCIX · General - Therapies · INJECTAFER · INSPIRE · Impella · JARDIANCE · LEQVIO · LEXISCAN · LINQ II · LifeVest · MITRACLIP · MOUNJARO · MULTAQ · Mitra Clip system · NEXLETOL · OPSUMIT · ORENITRAM · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Proclaim Family of SCS IPGs · RESONATE · Ranexa · Repatha · Rhythm Express · Rybelsus · SAMSCA · TEKTURNA · TELEPATCH CARDIAC MONITOR · TYVASO · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN Access System · WATCHMAN FLX · WINREVAIR · WatchPAT · WatchPATONE · XARELTO · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for cardiovascular disease in TX.

Equivalent to $4,679 per 100 Medicare services performed
Looking for a cardiovascular disease in Dallas?
Compare cardiovascular diseases in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
306
Per 100K population
11.8
County median income
$74,149
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Cheirif is a electrophysiology & cardiac specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 4%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Cheirif experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Cheirif performed 850 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cheirif receive payments from pharmaceutical companies?
Yes. Dr. Cheirif received a total of $141,545 from 48 companies across 508 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cheirif's costs compare to other cardiovascular diseases in Dallas?
Dr. Cheirif's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cheirif) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →